BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19321269)

  • 1. Comment on "Platelet-Rich Plasma as a novel therapeutic agent in osteomyelitis".
    Jia W; Zhang C
    Med Hypotheses; 2009 Aug; 73(2):270-1. PubMed ID: 19321269
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet-Rich Plasma as a novel therapeutic agent in osteomyelitis.
    Namazi H
    Med Hypotheses; 2007; 69(3):706. PubMed ID: 17462832
    [No Abstract]   [Full Text] [Related]  

  • 3. First report of successful treatment of chronic pediatric tibial osteomyelitis and fracture using autologous platelet-rich plasma.
    Qu K; Liu J; Chen H; Gao L; Wang S; Lv M
    Transfus Apher Sci; 2023 Dec; 62(6):103840. PubMed ID: 37925341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. By the way, doctor. What's your professional opinion of platelet-rich plasma therapy for soft tissue injuries? Is it safe for older adults?
    Robb-Nicholson C
    Harv Womens Health Watch; 2009 Aug; 16(12):8. PubMed ID: 19824181
    [No Abstract]   [Full Text] [Related]  

  • 5. [Can I continue to use platelet-rich-plasma on my patients? How do I use it legally?].
    Fernández Santos ME
    Rev Esp Cir Ortop Traumatol; 2014; 58(2):65-7. PubMed ID: 24674778
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of regeneration efficacy of parodontium tissue after application of autogenous bone with platelet rich plasma and biomaterials cerasorb with platelet rich plasma].
    Czuryszkiewicz-Cyrana J
    Ann Acad Med Stetin; 2008; 54(2):86-92. PubMed ID: 19374237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone and wound healing augmentation with platelet-rich plasma.
    Smith SE; Roukis TS
    Clin Podiatr Med Surg; 2009 Oct; 26(4):559-88. PubMed ID: 19778689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stored platelet concentrates produced by the platelet-rich plasma method are more resistant to apoptosis but more sensitive to activation than are platelets prepared by the buffy-coat and apheresis methods.
    Leytin V; Allen DJ; Mutlu A; Mykhaylov S; Lyubimov E; Freedman J
    Transfusion; 2009 Jul; 49(7):1493-4. PubMed ID: 19602211
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet-rich plasma: a literature review.
    Arora NS; Ramanayake T; Ren YF; Romanos GE
    Implant Dent; 2009 Aug; 18(4):303-10. PubMed ID: 19667818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-rich plasma compared with corticosteroid injection for chronic lateral elbow tendinosis.
    Mishra A; Collado H; Fredericson M
    PM R; 2009 Apr; 1(4):366-70. PubMed ID: 19627920
    [No Abstract]   [Full Text] [Related]  

  • 11. Shedding light in the controversial terminology for platelet rich products.
    Anitua E; Sánchez M; Orive G; Andía I
    J Biomed Mater Res A; 2009 Sep; 90(4):1262-3. PubMed ID: 18646198
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of platelet-rich plasma on bone healing of autogenous bone grafts in critical-size defects.
    Nagata MJ; Melo LG; Messora MR; Bomfim SR; Fucini SE; Garcia VG; Bosco AF; Okamoto T
    J Clin Periodontol; 2009 Sep; 36(9):775-83. PubMed ID: 19614722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring soluble platelet glycoprotein VI in human plasma by ELISA.
    Al-Tamimi M; Mu FT; Moroi M; Gardiner EE; Berndt MC; Andrews RK
    Platelets; 2009 May; 20(3):143-9. PubMed ID: 19437330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contamination of a donated platelet unit by Staphylococcus pasteuri.
    Savini V; Catavitello C; Pompetti F; Passeri C; Di Zacomo S; Esattore F; Iacone A; D'Antonio D
    J Infect; 2008 Dec; 57(6):494-6. PubMed ID: 19027171
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic potential of platelet rich plasma. Reflections on its research and development].
    González-Iglesias J
    Rev Esp Cir Ortop Traumatol; 2013; 57(4):237-9. PubMed ID: 23885648
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelial cells incubated with platelet-rich plasma express PDGF-B and ICAM-1 and induce bone marrow stromal cell migration.
    Cenni E; Ciapetti G; Granchi D; Fotia C; Perut F; Giunti A; Baldini N
    J Orthop Res; 2009 Nov; 27(11):1493-8. PubMed ID: 19396860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of the ability of platelet-rich plasma to seal an iatrogenic fetal membrane defect.
    Lewi L; Liekens D; Heyns L; Poliard E; Beutels E; Deprest J; Hoylaerts MF
    Prenat Diagn; 2009 Jun; 29(6):620-5. PubMed ID: 19340818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nosologico-therapeutic notes on osteomyelofibrosis].
    DI GUGLIELMO R
    G Gerontol; 1960 Jul; 8():467-74. PubMed ID: 13722505
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of the proportion of particulate autogenous bone graft/platelet-rich plasma on bone healing in critical-size defects: an immunohistochemical analysis in rat calvaria.
    Nagata M; Messora M; Okamoto R; Campos N; Pola N; Esper L; Sbrana M; Fucini S; Garcia V; Bosco A
    Bone; 2009 Aug; 45(2):339-45. PubMed ID: 19410024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of biomaterials with or without platelet-rich plasma in postextraction sites: a microscopic study in dogs.
    Camarini ET; Zanoni JN; Leite PC; Boos FB
    Int J Oral Maxillofac Implants; 2009; 24(3):432-8. PubMed ID: 19587864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.